Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News   Press Releases

28 Stocks Moving In Tuesday's Pre-Market Session

ALDX, CMCM, CPRX, KPRX, INO | March 26, 2019

Gainers

  • Aldeyra Therapeutics Inc (NASDAQ: ALDX) rose 65.3 percent to $11.80 in pre-market trading after the company's phase 3 trial for allergic conjunctivitis met its primary endpoint.
  • NanoViricides Inc (NYSE: NNVC) rose 41.5 percent to $0.44 in pre-market trading after the company requested a meeting with the FDA to prepare for a clinical trial.
  • Hunter Maritime Acquisition Corp. (NASDAQ: HUNT) rose 22.2 percent to $22.49 in pre-market trading after surging 96.90 percent on Monday. Piper Jaffray initiated coverage on the stock with an Overweight rating and announced a $200 price target.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) shares rose 19.2 percent to $16.53 in pre-market trading following media reports that three activist hedge funds plan to launch a proxy fight to replace all 12 current board members. Raymond James upgraded Bed Bath & Beyond from Market Perform to Strong Buy.
  • Biocept Inc (NASDAQ: BIOC) rose 13.6 percent to $1.17 in pre-market trading after the company announced it would apply its EmpowerTC product to urology. Also, Maxim Group initiated coverage on the stock with a Buy rating and $3 price target.
  • Inovio Pharmaceuticals Inc (NASDAQ: INO) rose 9.1 percent to $3.95 in pre-market trading after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating.
  • Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) rose 7.3 percent to $4.57 in pre-market trading after reporting grant of an additional new European patent for NurOwn.
  • The9 Limited (NASDAQ: NCTY) rose 7 percent to $2.15 in pre-market trading after falling 20.24 percent on Monday.
  • BeiGene, Ltd. (NASDAQ: BGNE) shares rose 5.8 percent to $133.32 in pre-market trading.
  • Coupa Software Incorporated (NASDAQ: COUP) rose 4.9 percent to $94.12 in pre-market trading.
  • ZTO Express (Cayman) Inc. (NYSE: ZTO) rose 4.5 percent to $18.64 in pre-market trading.
  • New Age Beverages Corporation (NASDAQ: NBEV) shares rose 4 percent to $5.46 in pre-market trading.
  • PagSeguro Digital Ltd. (NYSE: PAGS) rose 3.8 percent to $30.00 in pre-market trading.
  • Ciena Corporation (NYSE: CIEN) rose 3.5 percent to $38.60 in pre-market trading.
  • Eyegate Pharmaceuticals Inc (NASDAQ: EYEG) rose 3.1 percent to $0.40 in pre-market trading after the FDA said Eyegate is ready to move forward with a pivotal study for its Ocular Bandage Gel.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • OpGen Inc (NASDAQ: OPGN) fell 35.2 percent to $0.57 in pre-market trading after the company filed a 'Notice of Effectiveness' with the SEC. This indicates the company will proceed with a stock offering.
  • CAN-FITE BIOPHA/S ADR (NYSE: CANF) fell 31 percent to $0.89 in pre-market trading after the company's phase 2 trial for advanced liver cancer did not meet its primary endpoint.
  • Zomedica Pharmaceuticals Corp (NYSE: ZOM) fell 28 percent to $0.41 in pre-market trading after the company priced a 6.52 million share stock offering at $0.46 per share.
  • Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) shares fell 5.5 percent to $4.95 in pre-market trading after the company gave a corporate overview at Oppenheimer's healthcare event. Catalyst highlighted 2 possible catalysts in presentation: Phase 3 data for CMS, MuSK-MG candidates.
  • Akari Therapeutics, Plc (NASDAQ: AKTX) shares fell 5.2 percent to $3.50 in pre-market trading after dropping 10.00 percent on Monday.
  • Aptose Biosciences Inc. (NASDAQ: APTO) fell 4.9 percent to $2.16 in pre-market trading.
  • Inphi Corporation (NYSE: IPHI) fell 4.5 percent to $41.12 in pre-market trading.
  • China Bat Group, Inc. (NASDAQ: GLG) fell 4.4 percent to $2.39 in pre-market trading after rising 6.84 percent on Monday.
  • Orion Group Holdings, Inc. (NYSE: ORN) fell 3.8 percent to $3.07 in pre-market trading after reporting Q4 results.
  • Myokardia Inc (NASDAQ: MYOK) fell 3.6 percent to $50.01 in pre-market trading after reporting a $200 million offering of common stock.
  • iQIYI, Inc. (NASDAQ: IQ) fell 3.6 percent to $23.15 in pre-market trading after the company announced a $1.05 billion convertible note offering.
  • Cheetah Mobile Inc. (NYSE: CMCM) fell 3.4 percent to $6.77 in pre-market trading after rising 3.55 percent on Monday.
  • Cronos Group Inc (NASDAQ: CRON) fell 2 percent to $20.12 in pre-market trading following FY18 results.

© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Related News

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today